Skip to content
OpenCapital
Get started

Unicycive Therapeutics, Inc. UNCY Q4 2024 Annual earnings

Reported March 27, 2025 · Before market open

EPS-$0.16Miss by $0.03
EPS estimate-$0.13

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$22.2M
EPS estimate-$0.47

Versus estimates

Diluted EPS

Q1 2026-$0.54Miss by $0.08Q4 2025-$0.32Beat by $0.19Q3 2025-$0.39Beat by $0.20Q2 2025-$0.52Beat by $0.18Q1 2025-$0.26Miss by $0.13
Q4 2024-$0.16Miss by $0.03

Ask the moment Unicycive Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Unicycive Therapeutics, Inc. report Q4 2024 earnings?
Unicycive Therapeutics, Inc. (UNCY) reported Q4 2024 earnings on March 27, 2025 before market open.
What were Unicycive Therapeutics, Inc.'s Q4 2024 revenue and EPS?
Unicycive Therapeutics, Inc. reported eps of $-0.16 for Q4 2024.
Did Unicycive Therapeutics, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.13 by $0.03.
Where can I find Unicycive Therapeutics, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001213900-25-025828) directly on SEC EDGAR. The filing index links above go to sec.gov.